The Cigna Group header image

The Cigna Group

CI

Equity

ISIN US1255231003 / Valor 45558121

New York Stock Exchange, Inc (2024-12-26)
USD 281.58+0.54%

The Cigna Group
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

The Cigna Group operates as a global health service company through its various subsidiaries, including Cigna Health and Life Insurance Company, Cigna Health Management, Inc., and Evernorth Health, Inc., among others. These subsidiaries offer a wide range of health care-related services, such as health insurance, behavioral health services, care solutions, and dental health services. The company is committed to improving the health and well-being of its clients by focusing on quality and affordability in health care. This commitment is evidenced by its receipt of accreditation and certification from The National Committee for Quality Assurance (NCQA) and URAC, which are organizations dedicated to improving health care quality. These accreditations recognize Cigna Healthcare and Evernorth's efforts in managing health care delivery effectively, ensuring high standards of quality, and promoting continuous improvement in business processes. The company's approach integrates various aspects of health care services to provide comprehensive solutions aimed at enhancing patient care and outcomes.

Summarized from source with an LLMView SourceSector: Finance

Latest Results (17.12.2024):

Total Revenue Growth

The Cigna Group reported a significant increase in total revenues for the third quarter of 2024, reaching $63.7 billion. This marks a 30% growth compared to the same period in 2023, primarily driven by substantial growth in Evernorth Health Services, which benefited from large client wins and strong specialty volume growth.

Shareholders' Net Income

For the third quarter of 2024, The Cigna Group's shareholders' net income was $0.7 billion, or $2.63 per share. This figure includes a non-cash after-tax investment loss of $1.0 billion related to VillageMD, which impacted the earnings per share by $3.69. In comparison, the net income for the third quarter of 2023 was $1.4 billion, or $4.74 per share.

Adjusted Income from Operations

The Cigna Group's adjusted income from operations for the third quarter of 2024 was $2.1 billion, or $7.51 per share. This represents a 5% increase from the third quarter of 2023, which was $2.0 billion, or $6.77 per share. The growth was supported by strong contributions from Evernorth Health Services, particularly within Specialty and Care Services.

Segment Performance: Evernorth Health Services

Evernorth Health Services reported a 36% increase in adjusted revenues and a 9% increase in adjusted income from operations, pre-tax, for the third quarter of 2024 compared to the same period in 2023. The Pharmacy Benefit Services segment saw a 50% increase in adjusted revenues, while Specialty and Care Services experienced a 23% increase, driven by client wins and strong specialty volume growth.

2024 Outlook Reaffirmed

The Cigna Group has reaffirmed its 2024 outlook for adjusted income from operations, projecting at least $28.40 per share. This outlook reflects the company's confidence in its strategic execution and continued growth across its business segments, despite the dynamic market environment.

Summarized from source with an LLMView Source

Key figures

-6.18%1Y
24.7%3Y
37.8%5Y

Performance

27.3%1Y
26.3%3Y
33.4%5Y

Volatility

Market cap

78322 M

Market cap (USD)

Daily traded volume (Shares)

328,218

Daily traded volume (Shares)

1 day high/low

281.87 / 278.45

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Sydbank A/S
Sydbank A/S Sydbank A/S Valor: 2097040
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.90%DKK 369.60
KK Daishi Hokuetsu Financial Group
KK Daishi Hokuetsu Financial Group KK Daishi Hokuetsu Financial Group Valor: 41071317
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.03%JPY 2,885.00
Puig Brands SA
Puig Brands SA Puig Brands SA Valor: 134697076
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.80%EUR 17.71
Fukuoka Reit Toshi Hojin
Fukuoka Reit Toshi Hojin Fukuoka Reit Toshi Hojin Valor: 2177031
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.11%JPY 145,400.00
TISCO Financial Group Public Company Ltd
TISCO Financial Group Public Company Ltd TISCO Financial Group Public Company Ltd Valor: 4987299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.75%EUR 2.70
ChemoMetec A/S
ChemoMetec A/S ChemoMetec A/S Valor: 2817833
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%DKK 487.60
Quilter PLC
Quilter PLC Quilter PLC Valor: 117978175
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.19%GBP 1.54
Ichigo Office REIT Toshi Hojin
Ichigo Office REIT Toshi Hojin Ichigo Office REIT Toshi Hojin Valor: 2274865
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.76%JPY 81,100.00
Regional REIT Limited
Regional REIT Limited Regional REIT Limited Valor: 136428737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.40%GBP 1.19
Multitude P.L.C.
Multitude P.L.C. Multitude P.L.C. Valor: 136370116
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.21%EUR 4.80